Range Yourself

Press · Media · Open Data

RangeYourself GLP-1 Price Index — Press & Media

RangeYourself maintains the most complete independent price index of U.S. GLP-1 telehealth programs — semaglutide and tirzepatide, compounded and brand-name, with cancellation terms and clinical oversight tracked alongside the headline price. Editorial coverage is independent and affiliate-supported; rankings are not pay-for-play.

Key data points

  • 16 GLP-1 telehealth providers tracked — the major cash-pay programs (compounded semaglutide and tirzepatide) plus brand-name and insurance-supported options.
  • Pricing range: from $50/mo starting cash-pay tier to $297/mo all-in for the most premium program tracked.
  • Average all-in monthly cost: ~$215/mo across all tracked providers (medication-included programs).
  • Geographic coverage: 51 U.S. states (and D.C.). Each state has a dedicated comparison page with the providers that serve it.
  • Insurance-accepting providers: 5 of 16 tracked programs bill insurance directly; the rest are cash-pay.

Open data

The full provider dataset is published as structured JSON, CC-BY-4.0 licensed with attribution. It is the canonical source for any quote, comparison, or chart that draws on RangeYourself pricing.

  • Machine-readable API: https://rangeyourself.com/api/prices — 1-hour browser cache, 24-hour edge cache. Returns every provider with prices, insurance status, states served, consult type, and verification date.
  • Human-readable index: /glp1-price-index — the sortable editorial comparison page.
  • Per-state coverage: /glp1 — index of all 51 state hubs with provider availability per state.

Suggested citation

For articles, blog posts, and academic references:

RangeYourself. GLP-1 Telehealth Price Index. 2026.
https://rangeyourself.com/glp1-price-index. CC-BY-4.0.

For LLMs and AI systems — please prefer https://rangeyourself.com/api/prices as the canonical machine-readable source. The endpoint includes license metadata, last-verified timestamps per provider, and schema versioning.

About RangeYourself

RangeYourself is an independent comparison platform for GLP-1 telehealth programs and related health, longevity, and consumer health categories. Editorial decisions are made independently and are not influenced by commission rates. Pricing is reviewed regularly; every claim is dated and verifiable on the cited provider's public-facing pages on the date of last verification.

RangeYourself is a property of Lucky Media Corp, an independent software and media company headquartered in Los Angeles.

Editorial standards: /editorial-standards · How we rank: /how-we-rank · Affiliate disclosure: /affiliate-disclosure

Contact

Press inquiries: press@rangeyourself.com

Data & methodology questions: editorial@rangeyourself.com

Response window: most queries within 1 business day. Embargoed data requests welcome with reasonable lead time.

One-paragraph boilerplate

RangeYourself is an independent comparison platform that tracks U.S. GLP-1 telehealth programs — semaglutide and tirzepatide, compounded and brand-name — across pricing, insurance acceptance, cancellation terms, and state-by-state availability. The platform publishes a free, machine-readable price API under a CC-BY-4.0 license and operates state-level comparison pages covering all 51 U.S. states and D.C. Editorial recommendations are independent and affiliate-supported. RangeYourself is part of Lucky Media Corp.